Merck
MRK
#62
Rank
NZ$432.44 B
Marketcap
NZ$173.13
Share price
-1.16%
Change (1 day)
0.99%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): NZ$13.10

According to Merck's latest financial reports the company's current EPS (TTM) is NZ$13.18. In 2024 the company made an earnings per share (EPS) of NZ$11.74 an increase over its 2023 EPS that were of NZ$0.27.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$13.1011.64%
2024NZ$11.744308.46%
2023NZ$0.27-97.32%
2022NZ$9.9510.92%
2021NZ$8.9784.68%
2020NZ$4.86-27.2%
2019NZ$6.6763.44%
2018NZ$4.08151.11%
2017NZ$1.63-54.58%
2016NZ$3.5830.21%
2015NZ$2.75-61.99%
2014NZ$7.23180.51%
2013NZ$2.58-31.82%
2012NZ$3.786.62%
2011NZ$3.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.99-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.12 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$35.62 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.16-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.43-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
NZ$6.24-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$1.09-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
NZ$12.78-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
NZ$13.99 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$22.62 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA